METTL4 and neoplasm: Therefore, METTL4-mediated nuclear 6mA deposition inside nucleus controls hypoxia-induced gene expression and tumor metastasis through activating multiple metastasis-inducing targets, identifying METTL4 as a therapeutic target for hypoxia-involved tumors.